Filing Details
- Accession Number:
- 0001179110-15-006445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-20 16:06:20
- Reporting Period:
- 2015-03-29
- Filing Date:
- 2015-04-20
- Accepted Time:
- 2015-04-20 16:06:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1345695 | Bruce Leicher | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-29 | 6,750 | $0.00 | 137,862 | No | 4 | D | Direct | |
| Common Stock | Acquisiton | 2015-04-16 | 30,000 | $15.12 | 167,862 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-04-16 | 10,000 | $15.12 | 177,862 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-16 | 6,215 | $17.08 | 171,647 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-04-16 | 30,000 | $20.00 | 141,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-16 | 10,000 | $20.00 | 131,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-17 | 12,910 | $18.05 | 118,737 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | D | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-04-16 | 30,000 | $0.00 | 30,000 | $15.12 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-04-16 | 10,000 | $0.00 | 10,000 | $15.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,452 | 2012-08-19 | 2018-08-19 | No | 4 | M | Direct |
| 43,548 | 2012-08-19 | 2018-08-19 | No | 4 | M | Direct |
Footnotes
- Represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between Mr. Leicher and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Leicher and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2013.
- This transaction was executed in multiple trades at prices ranging from $18.00 to $18.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
